Drugmakers plan to raise US prices on at least 250 branded medications including Pfizer COVID-19 treatment Paxlovid, Bristol Myers Squibb's cancer cell therapies and vaccines from France's Sanofi at the start of 2025.
Nearly all of the drug price increases are below 10% - most well below.
The median price increase of the drug prices hiked on January is 4.5%, which is in line with the median for all price increases last year.
comments powered by Disqus